How big is the U.S. biotechnology market?

The U.S. biotechnology market size was estimated at USD 552.40 billion in 2023.

What is the U.S. biotechnology market growth?

The U.S. biotechnology market is expected to grow at a compound annual growth rate (CAGR) of 12.4% from 2024 to 2030 to reach USD 1.25 trillion by 2030.

Which segment accounted for the largest U.S. biotechnology market share?

The health segment dominated the market and accounted for the largest revenue market share of 44.3% in 2023. The use of biotechnology in healthcare is transforming the industry.

Who are the key players in the U.S. biotechnology market?

Some prominent players in the U.S. biotechnology market include AstraZeneca, Gilead Sciences, Inc., Bristol-Myers Squibb, Sanofi, Biogen, Abbott Laboratories, Pfizer, Inc. among others.

What are the factors driving the U.S. biotechnology market?

Government support plays a major role in propelling market growth, focusing on modernizing regulatory frameworks, enhancing approval processes and reimbursement policies, and standardizing clinical studies.